Cat.#: ACPP-1659
| Despition | Visfatin Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1675 | Human TOR1A Protein (AC1675) | 5 µg | inquiry |
| ACPP-1548 | Human FGF 19 Protein, His (AC1548) | 5 µg | inquiry |
| ACPP-1255 | MC3 Receptor Blocking Peptide (AC1255) | 250 µg | inquiry |
| ACPP-1142 | Recombinant Human TrkC Protein (Fc Tag) (AC1142) | 50 µg | inquiry |
| ACPP-1832 | Human CRYZ Protein (AC1832) | 5 µg | inquiry |
| ACPP-1050 | Recombinant Human LIF Protein (Fc Tag) (AC1050) | 50 µg | inquiry |
| ACPP-1641 | Adenylate cyclase 1 Blocking Peptide (AC1641) | 250 µg | inquiry |
| ACPP-1007 | Recombinant Human Secretogranin 3 Protein (6×His Tag) (AC1007) | 50 µg | inquiry |
| ACPP-1091 | BMP11 Blocking Peptide (AC1091) | 250 µg | inquiry |
| ACPP-1381 | Human DTNBP1 Protein (AC1381) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.